TDP2 Drives Immune Evasion and Metastatic Progression in Prostate Cancer

By
Emily Salmini
-
0
23
Researchers identified tyrosyl-DNA phosphodiesterase 2 (TDP2) as a key regulator within the tumor microenvironment and suggested its potential utility as both a prognostic biomarker and therapeutic target in prostate cancer.
[PloS One]
Full Article